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The prevalence ofStreptococcus pneumoniae (pneumococcus) carriage is higher in adults who are infected with
human immunodeficiency virus (HIV) than in adults who are not. We hypothesized that infants exposed to HIV be-
come carriers of nasopharyngeal pneumococcus earlier and more frequently than infants who are not exposed to
HIV. We compared infant pneumococcal acquisition by maternal HIV status and household exposure in Karonga
District, Malawi, in 2009–2011, before the introduction of pneumococcal conjugate vaccine. Nasopharyngeal
swabs were collected every 4–6 weeks in the first year of life from infants with known HIV-exposure status, their
mothers, and other household members. We studied infant pneumococcal acquisition by maternal HIV status,
serotype-specific household exposure, and other risk factors, including seasonality. We recruited 54 infants who
were exposed toHIV and 131 infants whowere not. Therewas no significant difference in pneumococcal acquisition
by maternal HIV status (adjusted rate ratio (aRR) = 1.00, 95% confidence interval (CI): 0.87, 1.15). Carriage by the
mother was associated with greater acquisition of the same serotype (aRR = 3.09, 95% CI: 1.47, 6.50), but the
adjusted population attributable fraction was negligible (1.9%, 95% CI: 0.0, 4.3). Serotype-specific exposure to
children under 5 years of age was associated with higher acquisition (aRR = 4.30, 95% CI: 2.80, 6.60; adjusted
population attributable fraction = 8.8%, 95% CI: 4.0, 13.4). We found no evidence to suggest that maternal HIV in-
fection would affect the impact of pneumococcal vaccination on colonization in this population.
Africa; carriage; cohort studies; HIV; infant; Streptococcus pneumoniae; transmission
Abbreviations: aRR, adjusted rate ratio; CI, confidence interval; HDSS, Health and Demographic Surveillance System; HIV, human
immunodeficiency virus; PAF, population attributable fraction; PCV13, 13-valent pneumococcal conjugate vaccine.
Streptococcus pneumoniae (pneumococcus) is a leading
cause of childhood morbidity and mortality worldwide. In
2013, pneumococcal pneumonia accounted for the largest
proportion of deaths from lower respiratory tract infections
and was estimated to cause 264,000 deaths in children less
than 5 years of age worldwide (1). Pneumococcal meningitis
was estimated to cause an additional 79,100 deaths in chil-
dren less than 5 years of age worldwide (1).
The nasopharynx is the primary portal for entry and source
for transmission of pneumococcus. Although colonization
with pneumococci is mostly asymptomatic, nasopharyngeal
carriage is thought to be a prerequisite for disease (2). In ad-
dition, asymptomatic carriers are the main source of pneumo-
coccal transmission, with person-to-person spread occurring
among persons in close contact with each other (2). Pneumo-
coccal acquisition occurs very early in life in low-income
countries, with an observed median time to acquisition of
only 38.5 days, 45.5 days, or 8 weeks reported in studies in
Kenya (3), Thailand-Myanmar (4), and Bangladesh (5), re-
spectively. This early and intense exposure in infancy is likely
to play a role in the high disease incidence also observed in
these settings.
Children born to mothers infected with human immunode-
ﬁciency virus (HIV) have been shown to experience higher
rates of respiratory illness (6). Although part of this association
is explained by HIV infection in the offspring, infants exposed
to HIV but not infected with it also appear to be at increased
risk of morbidity and mortality from invasive pneumococcal
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disease (7). In countries of sub-SaharanAfricawith generalized
HIV epidemics, HIV exposure occurs in up to 25% of pregnan-
cies. We hypothesized that infants born to mothers with HIV
would have higher rates of pneumococcal acquisition than in-
fants born to mothers without HIV and that this might lead to
increased rates of disease in the infants exposed to HIV. There
are 2 rationales for this hypothesis: 1) adults with HIV have
higher rates of pneumococcal carriage than adults without
HIV, resulting in a higher risk of exposure for the infants by
their parents (8), and 2) differences in immunity between chil-
dren exposed toHIVand thosewho are not, in particular altered
transfer of antibodies across the placenta and in breast milk,
might lead to different susceptibility to pneumococci (9).
We conducted a longitudinal household study inMalawi to
compare rates of pneumococcal acquisition among infants
whowere exposed toHIVversus infantswhowere not exposed.
We examined serotype-speciﬁc associations between infant
carriage and carriage in their mothers and household members
less than 5 years of age; both of these groups are hypothesized
to be key transmitters of pneumococcus to infants.
METHODS
Study population and design
The study was conducted in the area covered by the Karonga
Health andDemographic Surveillance System (HDSS) in north-
ern Malawi (10). Approximately 1,500 babies are born annual-
ly in the area. HIV prevalence in women of childbearing age
ranges from 3% inwomen 15–24 years of age to 16% inwomen
30–39 years of age (11). Pneumococcal conjugate vaccine had
not been introduced inMalawi at the time of sample collection.
Recruitment of pregnant women infected with HIV was
conducted in antenatal clinics in 2 rural hospitals between
January 2009 and December 2010. Attendance at antenatal
clinics was very high among pregnant women (99.7%) in the
HDSS area in 2009 and 2010. HIV testing was offered to all
women visiting the antenatal clinic. All pregnant womenwith
HIV living in the HDSS area were eligible for inclusion. For
each HIV-infected woman, up to 3 pregnant women with-
out HIV were recruited from the HDSS area and frequency
matched on the number of children less than 10 years of age
in the household. Nasopharyngeal swabs were collected from
the infant, the mother, and other household members willing
to participate when the infant was 6, 10, 14, 18, 22, 26, 30,
34, 40, 46, and 52 weeks of age. Follow-up ceased if the
index infant died, the mother-infant pair moved outside the
study area, consent was withdrawn, or there was a failure to
sample on 2 sequential visits. Available data for infants lost to
follow-up were included in the analyses.
Infants exposed to HIV were tested for HIV DNA at 6 and
26 weeks of age and for HIV antibodies at 12 months of age
or when visiting the local clinic as part of another afﬁliated
study. Infants with a positive antibody test at 12 months of
agewere followed to conﬁrmHIV status. Mothers and infants
with HIV were referred for appropriate care. Data regarding
antiretroviral therapy and cotrimoxazole prophylaxis were
available from databases linked to the HDSS. A retrospective
questionnaire was used for veriﬁcation and the collection of
missing data.
Laboratory procedures
Nasopharyngeal samples were collected and analyzed ac-
cording to standard procedures (12). A calcium alginate swab
(Medical Wire & Equipment, Corsham, United Kingdom)
was inserted into the posterior nasopharynx. The swab was
transported in a medium containing skim milk, tryptone, glu-
cose, and glycerol. Inoculated vials were stored at −20°C
within 6 hours of collection and were frozen at −80°C until
tested. Samples were cultured on gentamicin (5 µg/mL) sheep
blood agar plates and incubated overnight at 37°C with 5%
carbon dioxide. Pneumococci were identiﬁed bymorphology
and sensitivity to optochin. One colony was isolated and cul-
tured in Todd-Hewitt broth. Pneumococci were serogrouped
using the latex agglutination method and serotyped using the
Quellung method with standard antisera (Statens Serum Insti-
tut, Copenhagen, Denmark). Reagents were available to type
48 of the 92 possible serotypes, including the serotypes covered
by the 13-valent pneumococcal conjugate vaccine (PCV13): 1,
3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, and 23F.
Definitions
An episode of pneumococcal carriage was deﬁned as iso-
lation of pneumococcus from 1 or more consecutive samples.
An episode was deemed to be over if the serotype was not de-
tected in 2 consecutive samples. A new acquisition event was
deﬁned as the identiﬁcation of a serotype that had not been
identiﬁed in the previous 2 samples. We stratiﬁed the analy-
ses by PCV13 serotypes and by the major serotypes associ-
ated with colonization and invasive pneumococcal disease in
children (4, 6A, 6B, 9V, 14, 18C, 19A, 19F, and 23F). Pneu-
mococcal isolates identiﬁed in the ﬁrst sample were regarded
as new acquisitions. The date of acquisition was deﬁned
as the midpoint between the last negative result and the ﬁrst
positive result. The date of termination was deﬁned as the
midpoint between the last positive result and the ﬁrst of 2
negative results. We deﬁned pneumococcal exposure as car-
riage by another household member at any of the previous
2 sampling times. We deﬁned concordance in carriage as
simultaneous carriage of the same serotype by the infant and
household members. Negative results and results that could
not be typed with available antisera were excluded from the
concordance analyses.
Statistical analysis
Statistical analyses were performed using R, version 3.0.1
(R Foundation for Statistical Computing, Vienna, Austria)
(13). Comparisons of categorical data were made using
Pearson’s χ2 test and Fisher’s exact test as appropriate. Dif-
ferences in duration of carriage were calculated using the
Mann-Whitney U test. Details about calculation of duration
of carriage can be found in Web Appendix 1, available at
http://aje.oxfordjournals.org/. We used survival analysis, in-
cluding Kaplan-Meier plots and log-rank tests, to study dif-
ferences in the mean time to ﬁrst pneumococcal acquisition
(14). Crude and adjusted risk ratios for risk factors associated
with acquisition of any pneumococcal serotype were obtained
using log-binomial regression models (15). The associations
with infant age and seasonal and secular trends were studied
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with ﬁtted splines using generalized additive models. Secular
trends were further studied by serotype using generalized ad-
ditive models and the χ2 test for trend in proportions. For sea-
sonal trends, parametric functions with different numbers of
sin-cosinewaves were examined (seeWebAppendix 2). In ad-
dition, generalized linear and additive mixed models with
individual-level random effects were ﬁtted to examine the ex-
tent of within-person clustering (16, 17).
Serotype-speciﬁc analyses of household exposure were
performed for the 6 most common serotypes for infants,
mothers, and children less than 5 years of age.Acquisition and
exposurewere assessed at each sampling, and the results were
pooled to obtain a summary estimate. Crude and adjusted
population attributable fractions (PAF and aPAF, respec-
tively) of exposure from mothers, infants, and children less
than 5 years of age—the proportions of new acquisitions in
the population that are attributable to exposure—were calcu-
lated using the following formula:
PAF ¼ PeðRR  1Þ=½1þ PeðRR  1Þ;
where Pe is the proportion of individuals exposed and RR is
the rate ratio (rate in exposed/rate in unexposed). The PAF
was adjusted using the adjusted rate ratio obtained in the mul-
tivariable log-binomial model.
Ethics
Informed written consent was obtained from mothers and
heads of participating households. Ethical approval was
granted by the National Health Sciences Research Committee
in Malawi (protocol 490) and the London School of Hygiene
and Tropical Medicine ethics committee (protocol 5345).
RESULTS
Study participants and samples
Between January 2009 and December 2010, we recruited
54 infantswhowere exposed toHIVand 131 infantswhowere
not exposed to HIV. Follow-up ended in November 2011.
Follow-up ended prematurely for 24 infants (13%): 9 de-
parted from the study area, 7 died in the ﬁrst year of life, 6
were lost to follow-up, 1 was withdrawn from the study, and
1 left for other reasons. Of the 7 infants who died, 4 had been
exposed to HIV and 3 had not (P = 0.22). HIV test results
were available for 44 infants exposed to HIV (81.5%), of
whom 7 (15.9%) tested positive.
At least 1 nasopharyngeal swab was available for 140 of
168 (83.3%) children less than 5 years of age, 198 of 288
(68.8%) children 5–14 years of age, and 95 of 287 (33.1%)
adults other than the mother. In total, 1,721 results (90.2% of
scheduled visits) were available from index infants, 1,763
(92.4%) from mothers, 806 (46.3%) from children less than
5 years of age, 718 (24.1%) from children 5–14 years of age,
and 200 (6.8%) from other adult members of the household.
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Figure 1. Prevalence of pneumococcal carriage by age of the index
infant (weeks), Karonga District, Malawi, 2009–2011. Bars, 95% con-
fidence intervals.
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Figure 2. Kaplan-Meier plot for time to first acquisition of pneumo-
coccal carriage in infants by human immunodeficiency virus (HIV)
exposure status, Karonga District, Malawi, 2009–2011.
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Figure 3. Kaplan-Meier plot for time to first acquisition of pneumo-
coccal carriage in infants by the presence or absence of other children
less than 5 years of age in the household, Karonga District, Malawi,
2009–2011.
72 Heinsbroek et al.
Am J Epidemiol. 2016;183(1):70–78
D
ow
nloaded from
 https://academ
ic.oup.com
/aje/article-abstract/183/1/70/2195475 by U
niversity of G
lasgow
 user on 08 M
ay 2019
Information about the use of cotrimoxazole prophylaxis
and antiretroviral treatment was available for 46 infants ex-
posed to HIV (85.2%), of whom 18 (39.1%) received cotri-
moxazole and 3 (6.5%) received antiretroviral treatment
during the study period. Information about the use of cotri-
moxazole and antiretroviral treatment was available for 50
mothers with HIV (92.6%): 39 (78.0%) received cotrimoxa-
zole during all (n = 31) or part (n = 8) of the study period, and
28 (56.0%) received antiretroviral treatment during all (n =
24) or part (n = 4) of the study period.
Prevalence of pneumococcal carriage
The prevalence of pneumococcal carriage in the index
infants increased from 30.6% at week 6 to 60.6% at week
18 (P < 0.001) and subsequently decreased to 25.0% at week
52 (P < 0.001) (Figure 1). Overall pneumococcal carriage
prevalence was higher in mothers with HIV than in mothers
without HIV (24.8% vs. 14.5%; P < 0.001). Carriage preva-
lence did not differ signiﬁcantly between HIV-infected moth-
ers who used antiretroviral treatment and those who did not
(26.2% vs. 25.5%;P = 0.94) or between thosewho used cotri-
moxazole and those who did not (27.1% vs. 23.2%; P =
0.42). Overall pneumococcal carriage prevalence was 51.2%
in children less than 5 years of age, 40.3% in children 5–
14 years of age, and 17.5% in adults. Carriage in other chil-
dren in the household mirrored the differences by week
observed for index infants, with higher carriage observed
in earlier sampling weeks: 64.7% in week 14 versus 27.1%
in week 52 (P < 0.001) for children less than 5 years of age
and 50% in week 14 versus 15.2% in week 52 (P < 0.001) for
children 5–14 years of age. Carriage in mothers and other
adult household members did not differ signiﬁcantly by sam-
pling week.
The HIV status of the mother did not result in signiﬁcantly
different pneumococcal carriage prevalence in index infants
(44.1% in infants not exposed to HIV vs. 46.2% in infants
exposed to HIV; P = 0.44), children less than 5 years of age
(50.7% in those who were not exposed to HIV vs. 53.4% in
those who were; P = 0.60), or children 5–14 years of age
(41.5% in those who were not exposed to HIV vs. 36.9% in
those who were; P = 0.30). Carriage duration was longer for
infants (median, 39.5 days) than for mothers (median, 28.5
days; P = 0.008) and children less than 5 years of age (me-
dian, 28.5 days; P < 0.001) (Web Appendix 1, Web Table 1).
Serotype distribution
In total, 46 different serotypes of pneumococcus were iso-
lated from the infants. The most common serotypes were 19F,
19A, 6B, 23F, 6A, and 15B, together accounting for 47.6% of
isolates. PCV13 serotypes accounted for 54.7%, 48.4%, 40.8%,
34.4%, and 25.7% of isolates in index infants, children less
than 5 years of age, children 5–14 years of age, mothers, and
other adults, respectively. The major serotypes associated
with carriage and diseases in children accounted for 52.4%,
45.0%, 34.6%, 31.2%, and 20.0% of isolates in index infants,
children less than 5 years of age, children 5–14 years of age,
mothers, and other adults, respectively. There were no signif-
icant differences in the proportion of PCV13 serotypes or
common pediatric serotypes in infants or children who were
exposed to HIV compared with those who were not. Mothers
with HIV carried lower proportions of pediatric serotypes than
mothers who did not haveHIV (24.4%vs. 35.9%;P = 0.04). A
large proportion of isolates could not be fully typed with the
available reagents: 22.6%, 33.7%, 32.5%, 43.2%, and 48.6%
in index infants, children less than 5 years of age, children 5–
14 years of age, mothers, and other adults, respectively.
Concordance between serotypes simultaneously carried by
mothers and infants was low: In only 39 of 586 (6.7%) in-
stances in which the infant carried a typable pneumococcus
was the same serotype found in themother. Concordancewith
maternal carriage was 9.1% (15 of 165) in infants less than 3
months of age. Concordance with infant serotype carriage at
any age was 17.4% (49 of 281) for children less than 5 years
of age, 9.1% (19 of 209) for children 5–14 years of age, and
4.5% (3 of 66) for adults.
Pneumococcal acquisition in infants
There were 553 new acquisitions observed in index infants
during 59,365 days at risk, resulting in an acquisition rate
of 0.0093 per day (95% conﬁdence interval (CI): 0.0086,
0.0101). The observedmedian time to ﬁrst acquisition was 59
days, with no difference observed between infants exposed to
HIV (median time, 58.5 days) and those not exposed to HIV
(median time, 59.0 days; P = 0.99) (Figure 2). Infants living
with children less than 5 of age years acquired pneumococci
faster than infants without children less than 5 years of age in
the household (median time to ﬁrst acquisition, 56.5 days vs.
83.0 days; P = 0.001) (Figure 3).
Table 1 presents results from the univariable and multivar-
iable risk factor analyses for acquisition of pneumococcal
carriage in infants. There was no signiﬁcant difference in
pneumococcal acquisition by maternal HIV status (adjusted
rate ratio (aRR) = 1.00, 95%CI: 0.87, 1.15) or infant HIV status
(aRR = 1.00, 95%CI: 0.71, 1.42). Infant agewas not found to
be associatedwith pneumococcal acquisition (WebAppendix
2,Web Table 2,Web Figure 1). Therewas weak evidence that
cotrimoxazole prophylaxis reduced pneumococcal carriage ac-
quisition among infants exposed to HIV (aRR = 0.77, 95% CI:
0.59, 1.02). Similar results were found using Cox proportional
hazards models (Web Appendix 3, Web Table 3).
Household exposure
In the pooled analysis for the 6 most common serotypes,
both serotype-speciﬁc exposure by the mother (aRR = 3.09,
95% CI: 1.47, 6.50) and exposure by other children less
than 5 years of age (aRR = 4.30, 95% CI: 2.80, 6.60) were
found to be associated with infant pneumococcal acquisition
(Table 2). The aPAF was low for infant pneumococcal acqui-
sition: Only 1.9% (95% CI: 0.0, 4.3) and 8.8% (95% CI: 4.0,
13.4) of acquisitions were attributable to exposure by the
mother and by other children less than 5 years of age, respec-
tively (Table 2). Extreme case-sensitivity analysis changing
all missing exposure data to carriage or to noncarriage had
a limited impact on the calculated PAFs, suggesting that data
were missing at random (data not shown).
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Our results suggest that pneumococcal transmission oc-
curs between infants, other children, and mothers in all direc-
tions (Table 2). Only the association between pneumococcal
acquisition in other children less than 5 years of age and ex-
posure by the mother could not be established. For all groups,
exposure by children less than 5 years of age resulted in the
highest adjusted rate ratios and aPAFs, identifying them as
main transmitters in the household.
Seasonal and secular trends
A signiﬁcant seasonal trend was observed, with the highest
incidence occurring in August, corresponding to the cold sea-
son, and the lowest incidence in March, corresponding to the
end of the rainy season (P < 0.001) (Figure 4, Web Appendix
2,Web Table 2). Over the 2-year study period, pneumococcal
incidence showed a downward trend (P < 0.001) (Figure 5,
Web Appendix 2, Web Table 2). Acquisition of serotypes not
included in PCV13 showed a greater drop over the study
period (P < 0.001), and no drop in PCV13 serotypes was
observed (P = 0.82) (Web Appendix 4, Web Figure 2). For
serotype 19A, a rise was observed during the study period
(P < 0.001) (Web Appendix 4, Web Figure 2).
DISCUSSION
In this study, we observed similar rates of pneumococcal ac-
quisition among HIV-exposed and HIV-unexposed infants
in Malawi. Infant pneumococcal acquisition was associated
morewith carriage among children less than 5 years of age in the
household than with maternal carriage, but exposure from both
mothers andotherchildren less than5yearsof agecouldbe linked
only to a limited proportion of acquisitions in the infants.
There is no evidence that pneumococcal acquisition in in-
fants differsbymaternalHIVstatus, even thoughpneumococcal
prevalence was higher in mothers with HIV than in mothers
who did not have HIV. Similar ﬁndings were reported from a
South African study in which no difference in pneumococcal
Table 1. Crude and Adjusted Rate Ratios for Infant Pneumococcal Carriage Acquisition According to Maternal HIV Status and Other Associated
Risk Factors, Karonga District, Malawi, 2009–2011
Risk Factor No. of Samples
New
Acquisitions RR 95% CI aRR 95% CI
No. %
Age, weeks
6 183 56 30.6
10 171 65 38.0 1.24 0.93, 1.66 1.24 0.93, 1.64
14 168 55 32.7 1.07 0.79, 1.46 1.07 0.79, 1.44
18 165 64 38.8 1.27 0.95, 1.69 1.26 0.95, 1.68
22 152 47 30.9 1.01 0.73, 1.40 0.99 0.72, 1.37
26 157 58 36.9 1.21 0.90, 1.63 1.24 0.92, 1.66
30 152 49 32.2 1.05 0.77, 1.45 1.17 0.86, 1.59
34 145 33 22.8 0.74 0.51, 1.08 0.82 0.57, 1.18
40 144 64 44.4 1.45 1.09, 1.93 1.58 1.18, 2.11
46 144 38 26.4 0.86 0.61, 1.22 1.05 0.74, 1.50
52 140 24 17.1 0.56 0.37, 0.86 0.74 0.48, 1.14
Sex
Female 824 265 32.2
Male 897 288 32.1 1.00 0.87, 1.15 0.99 0.87, 1.13
Maternal HIV status
HIV-negative 1,219 381 31.3
HIV-positive 502 172 34.3 1.10 0.95, 1.27 1.00 0.87, 1.15
Child’s HIV statusa
HIV-negative 363 127 35.0
HIV-positive 69 23 33.3 0.95 0.66, 1.37 1.00 0.71, 1.42
Cotrimoxazole usea
No 311 112 36.0
Yes 152 46 30.3 0.84 0.63, 1.12 0.77 0.59, 1.02
Maternal age, years
<28 807 243 30.1
≥28 914 310 33.9 1.13 0.98, 1.29 1.05 0.92, 1.20
Table continues
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acquisition was found between infants on the basis of HIV ex-
posure (8). In the South African study, Nunes et al. reported an
association between colonization of the mother and infant (8),
but that study was not designed to determine the direction of
spread. In a mathematical modeling study of the same data,
Shiri et al. (18) concluded that children transmit pneumococci
more frequently to their mothers than vice versa. Our results
also suggest that transmission from infant to mother occurs fre-
quently, indicating the importance of deﬁning exposure by pre-
vious carriage rather than simultaneous carriage.
Although large associations were found for serotype-
speciﬁc exposure by the mother or other children less than
5 years of age, the proportion of acquisitions that could be ex-
plained by these exposures was small: only 1.9% and 8.8%,
respectively. It is likely that methodological limitations were
responsible for the small PAFs, as discussed below, but the
possibility of transmission from other household members
or from outside the household cannot be dismissed. Similar
results were found in a longitudinal study in the Gambia: The
probability of an infant ever carrying a particular serotype was
much greater if the mother had ever carried it (odds ratio =
9.1, 95% CI: 6.4, 13.6), but maternal carriage accounted for
only 9.5% of infant carriage (95% CI: 7.4, 11.6) (19).
PCV13 was introduced to the Malawi infant immunization
schedule in November 2011. It is not yet known whether the
effectiveness of PCV13 in this low-income and HIV-affected
population will be similar to the success of the vaccine in
high-income countries. Results from South Africa are prom-
ising, with similarly high vaccine effectiveness for 7-valent
pneumococcal conjugate vaccine against vaccine-serotype
invasive pneumococcal disease being found for both HIV-
negative infants exposed to HIV and infants who have not
been exposed to HIV (20). Moreover, in another study, HIV-
negative infants in South Africa who had been exposed to HIV
had higher antibody concentrations 3–6 weeks after vacci-
nation with 7-valent pneumococcal conjugate vaccine, possi-
bly due to less interference with maternal antibodies (21).
Infants too young to be fully vaccinated (<14 weeks of age)
will have to rely on the herd effect for protection. Our results
suggest that infants acquire pneumococcal carriage more often
from other children in the household who are less than 5 years
of age than they do from their mothers, allowing for indirect
vaccine protection if those children are vaccinated. Ongoing
surveillance of pneumococcal carriage after the introduction
of PCV13 is active in this population, with results expected
in early 2016.
Table 1. Continued
Risk Factor No. of Samples
New
Acquisitions RR 95% CI aRR 95% CI
No. %
Feeding
Exclusively breastfed 740 255 34.5
Mixed feeding 910 276 30.3 0.88 0.77, 1.01 1.04 0.82, 1.30
Weaned 49 15 30.6 0.89 0.58, 1.37 1.04 0.66, 1.65
Seasonality
Rainy season (December–April) 720 170 23.6
Cold season (May–August) 574 228 39.7 1.68 1.43, 1.99 1.59 1.35, 1.87
Hot season (September–November) 427 155 36.3 1.54 1.28, 1.84 1.37 1.13, 1.64
Year
2009 631 257 40.7
2010 810 236 29.1 0.72 0.62, 0.83 0.79 0.68, 0.91
2011 280 60 21.4 0.53 0.41, 0.67 0.62 0.48, 0.80
Other household members less than
5 years of age
No 515 149 28.9
Yes 1,206 404 33.5 1.16 0.99, 1.35 1.15 0.99, 1.33
Exposure by motherb
No 1,119 340 30.4
Yes 410 155 37.8 1.24 1.07, 1.45 1.14 0.98, 1.33
Exposure by other children less than
5 years of ageb
No 762 227 29.8
Yes 467 172 36.8 1.24 1.05, 1.45 1.07 0.90, 1.26
Abbreviations: aRR, adjusted rate ratio; CI, confidence interval; HIV, human immunodeficiency virus; RR, rate ratio.
a Including only HIV-exposed infants.
b Exposure to any serotype. Exposure was unknown for all week-6 samples.
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Pneumococcal carriage prevalence was lower in older in-
fants than in younger infants. Although this seemed to be re-
lated to infant aging, further analysis suggested that this was
not the case. Similar trends in carriage prevalence were ob-
served in older children in the household, for whom the aging
hypothesis is less likely. In the multivariable analysis in-
cluding infant aging, seasonal trends, and secular trends as
covariates, infant aging was found not to be signiﬁcantly
associated with acquisition of pneumococcal carriage; how-
ever, a signiﬁcant association was found for secular trends.
This suggests that the drop in carriage at later sampling points
was a result of a background drop in pneumococcal carriage.
Table 2. Serotype-Specific Acquistion of Pneumococcous Carriage Among Infants, Mothers, and Other Children
Less Than 5 Years of Age by Exposure to the Index Infant, Mother, and Other Children Less Than 5 Years of Age,
Karonga District, Malawi, 2009–2011
Acquiring Category,
Exposing Category,
and Exposurea
No. With
Events
No. Without
Events
Total
No.b
RR aRRc 95% CI
PAF,
%
aPAFb,
%
95% CI
Infant
Mother
Yes 8 69 77 3.95 3.09 1.47, 6.50 2.6 1.9 0.0, 4.3
No 225 8,335 8,560
Infant
Other child
Yes 22 173 195 4.70 4.30 2.80, 6.60 9.4 8.8 4.0, 13.4
No 162 6,593 6,755
Mother
Infant
Yes 13 474 487 4.83 3.89 1.98, 7.65 15.2 12.9 1.5, 23.1
No 55 9,894 9,949
Mother
Other child
Yes 9 236 245 5.75 3.99 1.82, 8.76 13.5 9.0 0.0, 17.6
No 46 7,154 7,300
Other child
Infant
Yes 15 228 243 2.22 1.86 1.06, 3.29 6.1 5.1 0.0, 11.2
No 121 4,227 4,348
Other child
Mother
Yes 1 52 53 0.65 0.33 0.04, 2.45 0.0 0.0 0.0, 0.4
No 113 3,777 3,890
Other child
Other child
Yes 7 57 64 3.99 3.17 1.50, 6.70 4.6 3.7 0.0, 7.9
No 108 3,835 3,943
Abbreviations: aPAF, adjusted population attributable fraction; aRR, adjusted rate ratio; CI, confidence interval;
PAF, population attributable fraction; RR, rate ratio.
a Exposure was defined as carriage by another household member at any of the previous 2 sampling times. Analysis
was limited to those samples for which exposure data for at least 1 of the 2 previous sampling times were available.
b The 6 most common serotypes (19F, 19A, 6B, 23F, 6A, and 15B) were assessed for acquisition and exposure at
each sampling time, and the results were pooled to obtain a summary estimate.
c Results were adjusted for exposure by the index child, exposure by children less than 5 years of age, exposure by
themother, seasonality stratified by year, and within-person clustering (mother only). Using a generalized linear mixed
model, therewas negligible individual-level variance for index infants (σ2 < 0.01) and other children less than 5 years of
age (σ2 < 0.01); therefore, results from a (nonmixed) generalized linear model were reported. Using a generalized
linear mixed model, the individual-level variance for mothers was 0.51.
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There is no obvious explanation for the overall drop in pneu-
mococcal acquisition over the study period. PCV13 was not
introduced in Malawi until November 2011. The observed
change in carriage incidence is contemporaneous with lower
rates of invasive disease in Malawi (22). Other possible ex-
planations are long-term ecological trends in pneumococcal
disease reﬂecting improved food security and nutrition in this
population.
There were several limitations to our study design. First,
the sampling interval of 4–6 weeks might not have been short
enough to detect all carriage episodes, especially in mothers,
whoclear pneumococcal carriage faster than children (23, 24).
Second, coverage of household members was incomplete,
particularly among older children and adults other than the
mother, who were often absent during study visits or refused
to participate. This precluded analyses on the role of older
children and adults in household transmission. Third, our lab-
oratory procedures did not allow for detection of simulta-
neous colonization with multiple serotypes. A subanalysis of
64 samples from 16 infants detected multiple serotypes in
51% of the samples (unpublished results). The low estimated
PAFs for exposure by mothers and children less than 5 years
of age might have been a result of this suboptimal detection
of carriage. Another limitation of our laboratory procedures is
that a large proportion of isolates could not be typed with
available reagents, resulting in fewer serotype results avail-
able for study of transmission within the household.
In conclusion, we did not ﬁnd evidence that maternal HIV
status affects pneumococcal acquisition among infants in this
African population. Infant pneumococcal acquisition is asso-
ciated with carriage in other children and mothers, but this
could explain only a limited proportion of acquisitions. Our
ﬁndings suggest that maternal HIV infection and infant expo-
surewill not affect the impact of the introduction of PCV13 in
thispopulation, although theextent towhichPCV13effective-
ness will match the success of this vaccine in high-income
settings remains to be established. We could not determine
from our study whether most infant pneumococcal carriage
is acquired within the household or in the community. Fur-
ther study of pneumococcal transmission in all age groups is
merited in order to add to our understanding of both vaccine
protection and the evolution of nonvaccine-serotype replace-
ment disease in the era of conjugate vaccine use.
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